1 |
(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 1件: 97💬 |
2 |
(r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid |
Butyric Acid |
1件: D05866 D05866💬 |
- |
- |
097 1件: 97💬 |
3 |
(s)-(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 1件: 97💬 |
4 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben |
- |
- |
- |
- |
097 1件: 97💬 |
5 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride |
- |
- |
- |
- |
097 1件: 97💬 |
6 |
-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162💬 |
- |
- |
096 2件: 96, 97💬 |
7 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97💬 |
8 |
0.25mg rpc103 |
- |
- |
- |
- |
097 1件: 97💬 |
9 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97💬 |
10 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97💬 |
11 |
1 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97💬 |
12 |
1.0 mg rpc103 |
- |
- |
- |
- |
097 1件: 97💬 |
13 |
1.0 mg rpc1063 |
- |
- |
- |
- |
097 1件: 97💬 |
14 |
1.remicade |
- |
- |
- |
- |
097 1件: 97💬 |
15 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 1件: 97💬 |
16 |
100 |
- |
- |
- |
- |
006 2件: 6 , 97💬 |
17 |
100 mg |
- |
- |
- |
- |
097 1件: 97💬 |
18 |
150 mg |
- |
- |
- |
- |
097 1件: 97💬 |
19 |
1500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
20 |
15n2-tofacitinib |
Tofacitinib |
1件: D09970 D09970💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97💬 |
21 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 1件: 97💬 |
22 |
2'-fucosyllactose |
- |
- |
- |
- |
096 2件: 96, 97💬 |
23 |
2-hydroxybenzoic acid |
Salicylic acid |
1件: D00097 D00097💬 |
- |
- |
097 1件: 97💬 |
24 |
20 mg |
- |
- |
- |
- |
097 1件: 97💬 |
25 |
225mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 1件: 97💬 |
26 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 2件: 96, 97💬 |
27 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97💬 |
28 |
250mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
29 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
2件: D00018 D00018, D03370 D03370💬 |
- |
- |
097 1件: 97💬 |
30 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
1件: D00396 D00396💬 |
- |
- |
096 2件: 96, 97💬 |
31 |
331731-18-1 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
32 |
40 mg msb11022 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
33 |
42942019 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
34 |
450 mg |
- |
- |
- |
- |
097 1件: 97💬 |
35 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 1件: 97💬 |
36 |
5-amino salicylic acid |
Salicylic acid |
1件: D00097 D00097💬 |
- |
- |
097 1件: 97💬 |
37 |
5-amino salicylic acid (5-asa) |
Mesalazine |
2件: D00097 D00097, D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
38 |
5-amino-2-hydroxybenzoic acid |
Salicylic acid |
1件: D00097 D00097💬 |
- |
- |
097 1件: 97💬 |
39 |
5-aminosalicyclic acid |
- |
- |
- |
- |
097 1件: 97💬 |
40 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 2件: 96, 97💬 |
41 |
5-aminosalicylic acid |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377💬 |
- |
- |
096 2件: 96, 97💬 |
42 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
43 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
3件: D00162 D00162, D00377 D00377, D00473 D00473💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
44 |
5-asa |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
096 2件: 96, 97💬 |
45 |
5-asa (5-aminosalicylate) |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
46 |
5-asa mmx |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
47 |
5-htp |
- |
- |
- |
- |
096 2件: 96, 97💬 |
48 |
50 mg |
- |
- |
- |
- |
097 1件: 97💬 |
49 |
500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
50 |
549-0261/f02-01 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
51 |
6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931💬 |
HPRT1 1件: HPRT1💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97💬 |
52 |
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid |
- |
- |
- |
- |
097 1件: 97💬 |
53 |
6-mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931💬 |
HPRT1 1件: HPRT1💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164💬 |
54 |
6-mp |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931💬 |
HPRT1 1件: HPRT1💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97💬 |
55 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97💬 |
56 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
57 |
75mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 1件: 97💬 |
58 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
2件: D00088 D00088, D00165 D00165💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
59 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
60 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97💬 |
61 |
[18f]fspg |
- |
- |
- |
- |
096 2件: 96, 97💬 |
62 |
[bi 655130] |
- |
- |
- |
- |
097 1件: 97💬 |
63 |
[cc-10004] |
- |
- |
- |
- |
097 1件: 97💬 |
64 |
[n/a] |
- |
- |
- |
- |
097 2件: 97, 299💬 |
65 |
A multistrain probiotic product (dsf) |
- |
- |
- |
- |
097 1件: 97💬 |
66 |
A07da03 |
- |
- |
- |
- |
097 1件: 97💬 |
67 |
A: 1 dosis |
- |
- |
- |
- |
097 1件: 97💬 |
68 |
Ab (antibiotics) |
- |
- |
- |
- |
097 1件: 97💬 |
69 |
Abalimumab |
- |
- |
- |
- |
097 1件: 97💬 |
70 |
Abatacept |
Abatacept |
1件: D03203 D03203💬 |
CD80 2件: CD80, CD86💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300💬 |
71 |
Abatacept (aba) |
Abatacept |
1件: D03203 D03203💬 |
CD80 2件: CD80, CD86💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
097 1件: 97💬 |
72 |
Abbv-006 |
- |
- |
- |
- |
097 1件: 97💬 |
73 |
Abbv-066 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
74 |
Abbv-323 |
- |
- |
- |
- |
053 2件: 53, 97💬 |
75 |
Abbv-323 dose a |
- |
- |
- |
- |
097 1件: 97💬 |
76 |
Abbv-323 dose b |
- |
- |
- |
- |
097 1件: 97💬 |
77 |
Abgn-168h |
- |
- |
- |
- |
097 1件: 97💬 |
78 |
Abi-m201 |
- |
- |
- |
- |
097 1件: 97💬 |
79 |
Abrilumab |
Abrilumab |
1件: D10540 D10540💬 |
ITGA4 2件: ITGA4, ITGB7💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97💬 |
80 |
Abt-494 |
- |
- |
- |
- |
041 6件: 41, 46, 49, 96, 97, 271💬 |
81 |
Abt-humira |
- |
- |
- |
- |
046 2件: 46, 97💬 |
82 |
Abx464 |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
83 |
Abx464 100mg |
- |
- |
- |
- |
046 2件: 46, 97💬 |
84 |
Abx464 25mg |
- |
- |
- |
- |
097 1件: 97💬 |
85 |
Abx464 50mg |
- |
- |
- |
- |
046 2件: 46, 97💬 |
86 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 2件: 96, 97💬 |
87 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 2件: 96, 97💬 |
88 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299💬 |
89 |
Acetic acid |
Acetic acid |
1件: D00010 D00010💬 |
- |
- |
097 1件: 97💬 |
90 |
Acidophilus |
Lactobacillus acidophilus |
1件: D04349 D04349💬 |
- |
- |
097 1件: 97💬 |
91 |
Active group |
- |
- |
- |
- |
097 1件: 97💬 |
92 |
Adalimumab |
Adalimumab |
1件: D02597 D02597💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271💬 |
93 |
Adipate |
Iron (III) oxide adipate |
- |
- |
- |
097 2件: 97, 228💬 |
94 |
Adipose derived, autologous mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97💬 |
95 |
Adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97💬 |
96 |
Adipose-cord mesenchymal stromal cells (a-mscs) |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
097 1件: 97💬 |
97 |
Aeb071 |
- |
- |
- |
- |
097 1件: 97💬 |
98 |
Aeb071a |
- |
- |
- |
- |
097 1件: 97💬 |
99 |
Ag011 |
- |
- |
- |
- |
097 1件: 97💬 |
100 |
Ag011 - capsules |
- |
- |
- |
- |
097 1件: 97💬 |
101 |
Ag011 - enema |
- |
- |
- |
- |
097 1件: 97💬 |
102 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299💬 |
103 |
Ajg501 |
- |
- |
- |
- |
097 1件: 97💬 |
104 |
Ajg511 |
- |
- |
- |
- |
097 1件: 97💬 |
105 |
Ajm300 |
- |
- |
- |
- |
097 1件: 97💬 |
106 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97💬 |
107 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 2件: 96, 97💬 |
108 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 4件: 46, 93, 97, 172💬 |
109 |
Allogeneic adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97💬 |
110 |
Allopurinol |
Allopurinol |
1件: D00224 D00224💬 |
XDH 1件: XDH💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97💬 |
111 |
Aloasc |
- |
- |
- |
- |
097 1件: 97💬 |
112 |
Aloe |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97💬 |
113 |
Aloe barbadensis miller |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97💬 |
114 |
Alth12-1:4 |
- |
- |
- |
- |
097 1件: 97💬 |
115 |
Alth12-2:4 |
- |
- |
- |
- |
097 1件: 97💬 |
116 |
Amg 181 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
117 |
Amg181 |
- |
- |
- |
- |
097 1件: 97💬 |
118 |
Amgevita |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
119 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
1件: D02597 D02597💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
120 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 2件: 96, 97💬 |
121 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 2件: 96, 97💬 |
122 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97💬 |
123 |
Amgevita® |
- |
- |
- |
- |
096 2件: 96, 97💬 |
124 |
Aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162💬 |
- |
- |
096 2件: 96, 97💬 |
125 |
Amitriptyline |
Amitriptyline |
2件: D00809 D00809, D07448 D07448💬 |
SLC6A2 2件: SLC6A2, SLC6A4💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
078 4件: 78, 97, 226, 299💬 |
126 |
Amitriptyline hydrochloride |
Amitriptyline |
2件: D00809 D00809, D07448 D07448💬 |
SLC6A2 2件: SLC6A2, SLC6A4💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
097 1件: 97💬 |
127 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299💬 |
128 |
Amoxicillin and tetracycline |
Amoxicillin |
4件: D00201 D00201, D00229 D00229, D02925 D02925, D07452 D07452💬 |
- |
- |
097 1件: 97💬 |
129 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
7件: D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452💬 |
- |
- |
097 1件: 97💬 |
130 |
Amt |
- |
- |
- |
- |
046 2件: 46, 97💬 |
131 |
Amt-101 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
132 |
Amt-101 (oral) |
- |
- |
- |
- |
097 1件: 97💬 |
133 |
Anakinra |
Anakinra |
1件: D02934 D02934💬 |
IL1R1 2件: IL1R1, IL1R2💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299💬 |
134 |
And (andrographolide) |
Andrographolide |
- |
- |
- |
097 1件: 97💬 |
135 |
Andecaliximab |
- |
- |
- |
- |
046 4件: 46, 96, 97, 299💬 |
136 |
Andosan |
- |
- |
- |
- |
096 2件: 96, 97💬 |
137 |
Andrographis paniculata |
- |
- |
- |
- |
097 1件: 97💬 |
138 |
Andrographis paniculata (ethanol extract) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542💬 |
- |
- |
097 1件: 97💬 |
139 |
Andrographolide |
Andrographolide |
- |
- |
- |
097 1件: 97💬 |
140 |
Anrukinzumab |
Anrukinzumab |
1件: D08857 D08857💬 |
IL13 1件: IL13💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
097 1件: 97💬 |
141 |
Anti beta7 |
- |
- |
- |
- |
097 1件: 97💬 |
142 |
Anti cd3 monoclonal antibody |
- |
- |
- |
- |
097 1件: 97💬 |
143 |
Anti tnf therapy including infliximab |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
144 |
Anti-cd3 |
Muromonab |
1件: D05092 D05092💬 |
CD3D 3件: CD3D, CD3E, CD3G💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97💬 |
145 |
Anti-cd3 monoclonal antibody |
Muromonab |
1件: D05092 D05092💬 |
CD3D 3件: CD3D, CD3E, CD3G💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97💬 |
146 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 2件: 96, 97💬 |
147 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97💬 |
148 |
Anti-ip-10 antibody |
- |
- |
- |
- |
097 1件: 97💬 |
149 |
Anti-madcam antibody |
- |
- |
- |
- |
096 2件: 96, 97💬 |
150 |
Anti-tl1a |
- |
- |
- |
- |
097 1件: 97💬 |
151 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 2件: 96, 97💬 |
152 |
Anti-tnf drug |
- |
- |
- |
- |
096 2件: 96, 97💬 |
153 |
Anti-tnf therapy |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
154 |
Anti-tnf: infliximab (infusion) |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
155 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
1件: D02597 D02597💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
156 |
Antibiotic cocktail |
- |
- |
- |
- |
097 1件: 97💬 |
157 |
Aodg (apigenin-7-o-glucuronide) |
Apigenin |
- |
- |
- |
097 1件: 97💬 |
158 |
Apd334 |
- |
- |
- |
- |
093 4件: 93, 96, 97, 269💬 |
159 |
Apigenin |
Apigenin |
- |
- |
- |
097 1件: 97💬 |
160 |
Apixaban |
Apixaban |
1件: D03213 D03213💬 |
F10 1件: F10💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 3件: 96, 97, 222💬 |
161 |
Apixaban 2.5 milligram |
Apixaban |
1件: D03213 D03213💬 |
F10 1件: F10💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 2件: 96, 97💬 |
162 |
Apremilast |
Apremilast |
1件: D08860 D08860💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271💬 |
163 |
Apriso 0.375g er cap |
- |
- |
- |
- |
097 1件: 97💬 |
164 |
Apriso 375 mg extended-release capsules |
- |
- |
- |
- |
097 1件: 97💬 |
165 |
Apvo210 |
- |
- |
- |
- |
097 1件: 97💬 |
166 |
Aquamin® |
- |
- |
- |
- |
097 1件: 97💬 |
167 |
Ar401959 l-arginine |
Arginine |
1件: D02982 D02982💬 |
- |
- |
096 2件: 96, 97💬 |
168 |
Arginine |
Arginine |
1件: D02982 D02982💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299💬 |
169 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271💬 |
170 |
As inn |
- |
- |
- |
- |
097 1件: 97💬 |
171 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251💬 |
172 |
Asacol |
- |
- |
- |
- |
097 1件: 97💬 |
173 |
Asacol (mesalamine) |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
174 |
Asacol (mesalamine) delayed-release tablets |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
175 |
Asacol 400 mg |
- |
- |
- |
- |
097 1件: 97💬 |
176 |
Asacol 400 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
177 |
Asacol 400 mg tablet |
- |
- |
- |
- |
097 1件: 97💬 |
178 |
Asacol 400mg tablet |
- |
- |
- |
- |
097 1件: 97💬 |
179 |
Asacol 800 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
180 |
Asacol 800 mg tablet |
- |
- |
- |
- |
097 1件: 97💬 |
181 |
Asacol 800mg tablet |
- |
- |
- |
- |
097 1件: 97💬 |
182 |
Asacol delayed release tablets |
- |
- |
- |
- |
097 1件: 97💬 |
183 |
Asacol delayed-release tablets |
- |
- |
- |
- |
097 1件: 97💬 |
184 |
Asacol tablet |
- |
- |
- |
- |
097 1件: 97💬 |
185 |
Asacol® |
- |
- |
- |
- |
097 1件: 97💬 |
186 |
Asacol® 400 mg |
- |
- |
- |
- |
097 1件: 97💬 |
187 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97💬 |
188 |
Ascorbic acid |
Ascorbic acid |
1件: D00018 D00018💬 |
- |
- |
010 4件: 10, 97, 206, 298💬 |
189 |
Asp015k |
- |
- |
- |
- |
046 2件: 46, 97💬 |
190 |
Asp3291 |
- |
- |
- |
- |
097 1件: 97💬 |
191 |
Aspergillus oryzae |
Aspergillus oryzae |
- |
- |
- |
097 1件: 97💬 |
192 |
Ast-120 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
193 |
Atl-2502 |
ATL-2502 |
- |
- |
- |
097 1件: 97💬 |
194 |
Avonex |
- |
- |
- |
- |
013 2件: 13, 97💬 |
195 |
Avx 470 |
- |
- |
- |
- |
097 1件: 97💬 |
196 |
Aza |
- |
- |
- |
- |
011 4件: 11, 40, 96, 97💬 |
197 |
Azafor 50mg |
- |
- |
- |
- |
097 1件: 97💬 |
198 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162💬 |
199 |
Azathioprine (aza) |
Azathioprine |
2件: D00238 D00238, D03033 D03033💬 |
- |
- |
013 3件: 13, 19, 97💬 |
200 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931💬 |
HPRT1 1件: HPRT1💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97💬 |
201 |
Azathioprine (imuran) 50 mg overencapsulated tablet |
Azathioprine |
2件: D00238 D00238, D03033 D03033💬 |
- |
- |
097 1件: 97💬 |
202 |
Azathioprine and allopurinol |
Allopurinol |
3件: D00224 D00224, D00238 D00238, D03033 D03033💬 |
XDH 1件: XDH💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
097 1件: 97💬 |
203 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931💬 |
HPRT1 1件: HPRT1💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97💬 |
204 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033💬 |
- |
- |
013 3件: 13, 96, 97💬 |
205 |
B2-asmedic |
- |
- |
- |
- |
097 1件: 97💬 |
206 |
B: 2 dosis |
- |
- |
- |
- |
097 1件: 97💬 |
207 |
Bacteriotherapy |
- |
- |
- |
- |
096 2件: 96, 97💬 |
208 |
Balsalazide |
Balsalazide |
2件: D02715 D02715, D07488 D07488💬 |
- |
- |
097 1件: 97💬 |
209 |
Balsalazide disodium |
Balsalazide |
2件: D02715 D02715, D07488 D07488💬 |
- |
- |
097 1件: 97💬 |
210 |
Baminercept |
Baminercept |
1件: D08866 D08866💬 |
LTB 1件: LTB💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97💬 |
211 |
Band |
- |
- |
- |
- |
006 2件: 6 , 97💬 |
212 |
Bascial prescription plus or minus herbs depend on symptoms |
- |
- |
- |
- |
097 1件: 97💬 |
213 |
Basiliximab |
Basiliximab |
1件: D03058 D03058💬 |
IL2RA 1件: IL2RA💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 6件: 2 , 50, 65, 97, 222, 228💬 |
214 |
Bbt-401-1s |
- |
- |
- |
- |
097 1件: 97💬 |
215 |
Bbt-401-1s, multiple doses |
- |
- |
- |
- |
097 1件: 97💬 |
216 |
Bbt-401-1s, single dose |
- |
- |
- |
- |
097 1件: 97💬 |
217 |
Beclometasone |
- |
- |
- |
- |
097 1件: 97💬 |
218 |
Beclometasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
085 2件: 85, 97💬 |
219 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 2件: 97, 98💬 |
220 |
Beclomethasone diproprionate |
- |
- |
- |
- |
097 1件: 97💬 |
221 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
222 |
Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) |
Lactobacillus acidophilus |
1件: D04349 D04349💬 |
- |
- |
097 1件: 97💬 |
223 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 1件: 97💬 |
224 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
225 |
Berberine |
Berberine |
1件: D00092 D00092💬 |
- |
- |
097 1件: 97💬 |
226 |
Berberine chloride |
Berberine |
1件: D00092 D00092💬 |
- |
- |
097 1件: 97💬 |
227 |
Bertilimumab |
- |
- |
- |
- |
097 2件: 97, 162💬 |
228 |
Beta-1,3/1,6-d-glucan |
- |
- |
- |
- |
097 1件: 97💬 |
229 |
Bezlotoxumab |
Bezlotoxumab |
1件: D10453 D10453💬 |
- |
- |
096 2件: 96, 97💬 |
230 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
1件: D04554 D04554💬 |
IFNAR1 2件: IFNAR1, IFNAR2💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97💬 |
231 |
Bg9924 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
232 |
Bi 655130 |
- |
- |
- |
- |
037 3件: 37, 96, 97💬 |
233 |
Biap |
- |
- |
- |
- |
046 2件: 46, 97💬 |
234 |
Bifidobacterium breve |
MRx-4DP0004 |
- |
- |
- |
097 1件: 97💬 |
235 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97💬 |
236 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97💬 |
237 |
Bimekizumab |
Bimekizumab |
1件: D11550 D11550💬 |
IL17A 2件: IL17A, IL17F💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 3件: 46, 97, 271💬 |
238 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
2件: D00115 D00115, D06892 D06892💬 |
- |
- |
097 1件: 97💬 |
239 |
Biologically active human fecal microbiota |
- |
- |
- |
- |
097 1件: 97💬 |
240 |
Biopsies |
- |
- |
- |
- |
097 1件: 97💬 |
241 |
Biosimilar |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
242 |
Biosimilar infliximab |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97💬 |
243 |
Bitter candytuft fresh plant extract |
- |
- |
- |
- |
097 1件: 97💬 |
244 |
Bitterschleifenblume-ganzpflanze 1,5ml/10ml |
- |
- |
- |
- |
097 1件: 97💬 |
245 |
Bl-7040 |
- |
- |
- |
- |
097 1件: 97💬 |
246 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299💬 |
247 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271💬 |
248 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271💬 |
249 |
Bms-936557 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
250 |
Bms-986165 |
- |
- |
- |
- |
049 3件: 49, 96, 97💬 |
251 |
Bms-986165 dose 1 |
- |
- |
- |
- |
097 1件: 97💬 |
252 |
Bms-986165 dose 2 |
- |
- |
- |
- |
097 1件: 97💬 |
253 |
Bms-986166 |
- |
- |
- |
- |
097 1件: 97💬 |
254 |
Bms-986184 |
- |
- |
- |
- |
097 1件: 97💬 |
255 |
Bms986165 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
256 |
Boulardii |
- |
- |
- |
- |
096 2件: 96, 97💬 |
257 |
Bovine intestinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97💬 |
258 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97💬 |
259 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97💬 |
260 |
Brazikumab |
Brazikumab |
1件: D10912 D10912💬 |
IL23A 1件: IL23A💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97💬 |
261 |
Broccoli |
Broccoli |
- |
- |
- |
036 3件: 36, 97, 299💬 |
262 |
Bt-11 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
263 |
Bt-11 (1000 mg) |
- |
- |
- |
- |
097 1件: 97💬 |
264 |
Bt-11 (500 mg) |
- |
- |
- |
- |
097 1件: 97💬 |
265 |
Bt-11 1000mg |
- |
- |
- |
- |
096 2件: 96, 97💬 |
266 |
Bt-11 500 mg |
- |
- |
- |
- |
096 2件: 96, 97💬 |
267 |
Bt-11 active |
- |
- |
- |
- |
096 2件: 96, 97💬 |
268 |
Budenofalk 2mg rectal foam |
- |
- |
- |
- |
097 1件: 97💬 |
269 |
Budenofalk 3mg |
- |
- |
- |
- |
093 2件: 93, 97💬 |
270 |
Budenofalk rectal foam |
- |
- |
- |
- |
097 1件: 97💬 |
271 |
Budenofalk® suppositories |
- |
- |
- |
- |
097 1件: 97💬 |
272 |
Budenofalk® suppositories (bus) |
- |
- |
- |
- |
097 1件: 97💬 |
273 |
Budesonide |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299💬 |
274 |
Budesonide (6 mg) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
275 |
Budesonide (9 mg) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
276 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
277 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
278 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
279 |
Budesonide 9 mg capsules, hard (bux-pv) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
280 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
281 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
282 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
283 |
Budesonide mmx |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
284 |
Budesonide mmx 6 mg tablet |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
285 |
Budesonide mmx® |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
286 |
Budesonide mmx® 6 mg |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
287 |
Budesonide mmx® 9 mg |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
288 |
Budesonide-mmx |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
289 |
Budesonide-mmx® |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
290 |
Budesonide-mmx® 6 mg |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
291 |
Budesonide-mmx® 9 mg |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
292 |
Budesonide-mmx™ |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
293 |
Butanoic acid |
Butyric Acid |
1件: D05866 D05866💬 |
- |
- |
034 3件: 34, 51, 97💬 |
294 |
Butyrate |
Butyric Acid |
1件: D05866 D05866💬 |
- |
- |
097 2件: 97, 291💬 |
295 |
By demand |
- |
- |
- |
- |
096 2件: 96, 97💬 |
296 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265💬 |
297 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97💬 |
298 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97💬 |
299 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299💬 |
300 |
Caltrate pill |
- |
- |
- |
- |
096 2件: 96, 97💬 |
301 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915💬 |
CNR1 2件: CNR1, CNR2💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271💬 |
302 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271💬 |
303 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97💬 |
304 |
Carbon |
Activated charcoal |
1件: D03251 D03251💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298💬 |
305 |
Carbon dioxide |
Activated charcoal |
2件: D00004 D00004, D03251 D03251💬 |
- |
- |
050 3件: 50, 51, 97💬 |
306 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316💬 |
307 |
Carrageenan |
- |
- |
- |
- |
097 1件: 97💬 |
308 |
Carvi extractum fluidum |
- |
- |
- |
- |
097 1件: 97💬 |
309 |
Casein |
Casein |
- |
- |
- |
097 1件: 97💬 |
310 |
Casein glycomacropeptide (cgmp) |
Casein |
- |
- |
- |
097 1件: 97💬 |
311 |
Cat-354 |
- |
- |
- |
- |
097 1件: 97💬 |
312 |
Catridecacog |
Catridecacog |
1件: D10532 D10532💬 |
- |
- |
097 2件: 97, 288💬 |
313 |
Cb-01-02 |
- |
- |
- |
- |
097 1件: 97💬 |
314 |
Cb-01-05-mmx |
- |
- |
- |
- |
097 1件: 97💬 |
315 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271💬 |
316 |
Cc-10004 |
- |
- |
- |
- |
046 5件: 46, 56, 97, 162, 271💬 |
317 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265💬 |
318 |
Ceftriaxone |
Ceftriaxone |
2件: D00924 D00924, D07659 D07659💬 |
- |
- |
002 3件: 2 , 6 , 97💬 |
319 |
Cefuroxime |
Cefuroxime |
4件: D00262 D00262, D00914 D00914, D00915 D00915, D03431 D03431💬 |
- |
- |
097 2件: 97, 299💬 |
320 |
Certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 6件: 37, 46, 96, 97, 226, 271💬 |
321 |
Cgmp protein |
- |
- |
- |
- |
097 1件: 97💬 |
322 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299💬 |
323 |
Chlorogenic acid |
Chlorogenic Acid |
- |
- |
- |
097 1件: 97💬 |
324 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188💬 |
VDR 1件: VDR💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299💬 |
325 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269💬 |
326 |
Ciclosporina |
Cyclosporine |
1件: D00184 D00184💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
049 3件: 49, 97, 228💬 |
327 |
Cimzia |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
328 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299💬 |
329 |
Cla |
- |
- |
- |
- |
097 1件: 97💬 |
330 |
Cla (chlorogenic acid) |
Chlorogenic Acid |
- |
- |
- |
097 1件: 97💬 |
331 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299💬 |
332 |
Clipper |
- |
- |
- |
- |
097 1件: 97💬 |
333 |
Clipper 30 cpr 5mg r.m. |
- |
- |
- |
- |
097 1件: 97💬 |
334 |
Clipper*30cpr 5mg r.m. |
- |
- |
- |
- |
097 1件: 97💬 |
335 |
Clotrimazole |
Clotrimazole |
1件: D00282 D00282💬 |
- |
- |
097 1件: 97💬 |
336 |
Cnto 148 |
- |
- |
- |
- |
046 4件: 46, 84, 97, 271💬 |
337 |
Cnto-148 |
- |
- |
- |
- |
097 1件: 97💬 |
338 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97💬 |
339 |
Cnto148 |
- |
- |
- |
- |
046 3件: 46, 84, 97💬 |
340 |
Cnto1959 |
- |
- |
- |
- |
037 3件: 37, 96, 97💬 |
341 |
Cnto312 |
- |
- |
- |
- |
097 1件: 97💬 |
342 |
Coamoxiclav |
- |
- |
- |
- |
097 1件: 97💬 |
343 |
Cobitolimod |
Cobitolimod |
- |
- |
- |
097 1件: 97💬 |
344 |
Coffee |
- |
- |
- |
- |
096 2件: 96, 97💬 |
345 |
Coffee coal |
- |
- |
- |
- |
097 1件: 97💬 |
346 |
Colal pred |
- |
- |
- |
- |
097 1件: 97💬 |
347 |
Colal-pred |
- |
- |
- |
- |
097 1件: 97💬 |
348 |
Colal-pred® |
- |
- |
- |
- |
097 1件: 97💬 |
349 |
Colazide |
- |
- |
- |
- |
097 1件: 97💬 |
350 |
Coltect |
- |
- |
- |
- |
097 1件: 97💬 |
351 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
2件: D00088 D00088, D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
352 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
353 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
354 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
2件: D00088 D00088, D00165 D00165💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
355 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222💬 |
356 |
Corticosteroids |
- |
- |
- |
- |
041 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300💬 |
357 |
Corticosteroids only |
- |
- |
- |
- |
097 1件: 97💬 |
358 |
Cortimentmmx 9 mg |
- |
- |
- |
- |
097 1件: 97💬 |
359 |
Cosmofer |
- |
- |
- |
- |
086 3件: 86, 96, 97💬 |
360 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 2件: 96, 97💬 |
361 |
Cotrimoxazole |
- |
- |
- |
- |
085 2件: 85, 97💬 |
362 |
Cp |
- |
- |
- |
- |
006 6件: 6 , 46, 96, 97, 107, 271💬 |
363 |
Cp- 690 550 |
- |
- |
- |
- |
097 1件: 97💬 |
364 |
Cp-690,500 5 mg |
- |
- |
- |
- |
097 1件: 97💬 |
365 |
Cp-690,550 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
366 |
Cp-690,550 10 mg |
- |
- |
- |
- |
097 1件: 97💬 |
367 |
Cp-690,550-10 |
- |
- |
- |
- |
046 5件: 46, 96, 97, 107, 271💬 |
368 |
Cp690,550 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
369 |
Cs (corticosteroids) only |
- |
- |
- |
- |
097 1件: 97💬 |
370 |
Ct-p13 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
371 |
Ct-p13 sc (infliximab) |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
372 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299💬 |
373 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326💬 |
374 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302💬 |
375 |
Cyclosporine (usan) |
Cyclosporine |
1件: D00184 D00184💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97💬 |
376 |
Cyclosporine vs infliximab |
Cyclosporine |
2件: D00184 D00184, D02598 D02598💬 |
PPP3CA 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway |
097 1件: 97💬 |
377 |
Cycol |
- |
- |
- |
- |
097 1件: 97💬 |
378 |
Cycol™ |
- |
- |
- |
- |
097 1件: 97💬 |
379 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 2件: 96, 97💬 |
380 |
D-proline |
D-Proline |
1件: D00035 D00035💬 |
- |
- |
097 1件: 97💬 |
381 |
Daclizumab |
Daclizumab |
1件: D03639 D03639💬 |
IL2RA 1件: IL2RA💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 7件: 13, 56, 60, 65, 97, 283, 284💬 |
382 |
Dacortin |
- |
- |
- |
- |
097 1件: 97💬 |
383 |
Dand (14-deoxyandrographolide) |
- |
- |
- |
- |
097 1件: 97💬 |
384 |
Ddand (14-deoxy-11,12-didehydroandrographolide) |
- |
- |
- |
- |
097 1件: 97💬 |
385 |
Decortin h |
- |
- |
- |
- |
066 3件: 66, 97, 145💬 |
386 |
Decortin h 1 mg |
- |
- |
- |
- |
097 1件: 97💬 |
387 |
Decortin h 10mg |
- |
- |
- |
- |
097 1件: 97💬 |
388 |
Decortin h 20mg |
- |
- |
- |
- |
097 1件: 97💬 |
389 |
Decortin h 50 mg |
- |
- |
- |
- |
097 1件: 97💬 |
390 |
Decortin h 5mg |
- |
- |
- |
- |
097 1件: 97💬 |
391 |
Dekavil |
- |
- |
- |
- |
046 2件: 46, 97💬 |
392 |
Dekristol |
- |
- |
- |
- |
013 2件: 13, 97💬 |
393 |
Delayed and extended release mesalazine |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
394 |
Deligoparin |
- |
- |
- |
- |
097 1件: 97💬 |
395 |
Delmitide acetate |
Acetate |
- |
- |
- |
097 1件: 97💬 |
396 |
Deltacortene |
- |
- |
- |
- |
043 2件: 43, 97💬 |
397 |
Deltacortene 10 cpr 25mg |
- |
- |
- |
- |
097 1件: 97💬 |
398 |
Deltacortene 20 cpr 5mg |
- |
- |
- |
- |
097 1件: 97💬 |
399 |
Deltacortene forte*10cpr 25mg |
- |
- |
- |
- |
046 2件: 46, 97💬 |
400 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 3件: 49, 97, 113💬 |
401 |
Dersalazina sodica |
- |
- |
- |
- |
097 1件: 97💬 |
402 |
Dersalazine |
Dersalazine |
- |
- |
- |
097 1件: 97💬 |
403 |
Dersalazine sodium |
Dersalazine |
- |
- |
- |
097 1件: 97💬 |
404 |
Device: the colonic transendoscopic enteral tubing. |
- |
- |
- |
- |
097 1件: 97💬 |
405 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299💬 |
406 |
Dexamethasone 21-phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
407 |
Dextran |
Dextran |
1件: D00060 D00060💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97💬 |
408 |
Dextran 1 for injection |
Dextran |
1件: D00060 D00060💬 |
- |
- |
097 1件: 97💬 |
409 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156💬 |
410 |
Dextromethorphan 30 mg |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 2件: 96, 97💬 |
411 |
Diagnostic test: antibodies to golimumab |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
412 |
Diagnostic test: calprotectin |
- |
- |
- |
- |
097 1件: 97💬 |
413 |
Diagnostic test: colonoscopy |
- |
- |
- |
- |
097 1件: 97💬 |
414 |
Diagnostic test: golimumab trough levels |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
415 |
Diagnostic test: histology |
- |
- |
- |
- |
097 1件: 97💬 |
416 |
Diagnostic test: parasitological diagnostics (coproscopy) |
- |
- |
- |
- |
097 1件: 97💬 |
417 |
Diagnostic test: rectosigmoidoscopy |
- |
- |
- |
- |
097 1件: 97💬 |
418 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
1件: D00030 D00030💬 |
- |
- |
096 2件: 96, 97💬 |
419 |
Diet |
- |
- |
- |
- |
097 3件: 97, 240, 299💬 |
420 |
Dims0150 |
- |
- |
- |
- |
097 1件: 97💬 |
421 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299💬 |
422 |
Dukoral |
- |
- |
- |
- |
097 1件: 97💬 |
423 |
E. coli nissle |
- |
- |
- |
- |
097 1件: 97💬 |
424 |
E6007 |
- |
- |
- |
- |
097 1件: 97💬 |
425 |
Ecologic 825 |
- |
- |
- |
- |
097 1件: 97💬 |
426 |
Egf enema |
- |
- |
- |
- |
097 1件: 97💬 |
427 |
Eicosapentaenoic acid |
Icosapent |
1件: D08061 D08061💬 |
- |
- |
049 5件: 49, 96, 97, 296, 297💬 |
428 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
429 |
Emea/h/c/000481 |
- |
- |
- |
- |
097 1件: 97💬 |
430 |
En |
- |
- |
- |
- |
006 3件: 6 , 46, 97💬 |
431 |
Encapsulated faecal microbiota |
- |
- |
- |
- |
097 1件: 97💬 |
432 |
Encapsulated faecal microbiota filtrate |
- |
- |
- |
- |
097 1件: 97💬 |
433 |
Encapsulated mesalamine granules (emg) |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
434 |
Entecavir |
Entecavir |
2件: D04008 D04008, D07896 D07896💬 |
- |
- |
046 5件: 46, 56, 96, 97, 271💬 |
435 |
Entocort cr |
- |
- |
- |
- |
096 2件: 96, 97💬 |
436 |
Entocort ec® 3 mg |
- |
- |
- |
- |
097 1件: 97💬 |
437 |
Entocort® cr |
- |
- |
- |
- |
097 1件: 97💬 |
438 |
Entyvio |
- |
- |
- |
- |
094 3件: 94, 96, 97💬 |
439 |
Entyvio 300 mg |
- |
- |
- |
- |
097 1件: 97💬 |
440 |
Entyvio 300mg |
- |
- |
- |
- |
097 1件: 97💬 |
441 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 2件: 96, 97💬 |
442 |
Epidermal growth factor |
- |
- |
- |
- |
097 1件: 97💬 |
443 |
Epidermal growth factor enema |
- |
- |
- |
- |
097 1件: 97💬 |
444 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187💬 |
VDR 1件: VDR💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299💬 |
445 |
Ethanol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542💬 |
- |
- |
051 4件: 51, 97, 279, 280💬 |
446 |
Etrasimod |
Etrasimod |
1件: D10930 D10930💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97💬 |
447 |
Etrasimod l-arginine |
Arginine |
2件: D02982 D02982, D10930 D10930💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97💬 |
448 |
Etrolizumab |
Etrolizumab |
1件: D09901 D09901💬 |
ITGB7 1件: ITGB7💬 |
Arrhythmogenic right ventricular cardiomyopathy 11件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 2件: 96, 97💬 |
449 |
Etrozulimab |
- |
- |
- |
- |
097 1件: 97💬 |
450 |
Exposure to golimumab |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
451 |
F8il10 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
452 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 3件: 51, 97, 288💬 |
453 |
Faecal matter |
- |
- |
- |
- |
097 1件: 97💬 |
454 |
Faecal microbiota transplant |
- |
- |
- |
- |
097 1件: 97💬 |
455 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 2件: 96, 97💬 |
456 |
Fe 999301 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
457 |
Fecal microbial transplant |
- |
- |
- |
- |
096 2件: 96, 97💬 |
458 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 2件: 96, 97💬 |
459 |
Fecal microbiota |
- |
- |
- |
- |
013 3件: 13, 96, 97💬 |
460 |
Fecal microbiota capsule |
- |
- |
- |
- |
097 1件: 97💬 |
461 |
Fecal microbiota enema |
- |
- |
- |
- |
097 1件: 97💬 |
462 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 2件: 96, 97💬 |
463 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 2件: 96, 97💬 |
464 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97💬 |
465 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 2件: 96, 97💬 |
466 |
Fecal microbiota transplantation (fmt), openbiome |
- |
- |
- |
- |
097 1件: 97💬 |
467 |
Ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920💬 |
- |
- |
086 4件: 86, 96, 97, 299💬 |
468 |
Ferrous sulphate |
- |
- |
- |
- |
096 2件: 96, 97💬 |
469 |
Filgotinib |
Filgotinib |
1件: D10871 D10871💬 |
JAK1 1件: JAK1💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271💬 |
470 |
Film-coated tablet |
- |
- |
- |
- |
097 1件: 97💬 |
471 |
Fitc-adalimumab |
Adalimumab |
1件: D02597 D02597💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
472 |
Flagyl |
- |
- |
- |
- |
096 2件: 96, 97💬 |
473 |
Flaxseed |
- |
- |
- |
- |
097 2件: 97, 299💬 |
474 |
Flaxseed lignan-enriched complex (flc) |
- |
- |
- |
- |
097 1件: 97💬 |
475 |
Flixabi |
- |
- |
- |
- |
096 2件: 96, 97💬 |
476 |
Fluorescein |
Fluorescein |
2件: D01261 D01261, D02024 D02024💬 |
- |
- |
019 2件: 19, 97💬 |
477 |
Flupentixol |
Flupentixol |
1件: D01044 D01044💬 |
DRD1 2件: DRD1, DRD2💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
097 1件: 97💬 |
478 |
Fmt |
- |
- |
- |
- |
096 2件: 96, 97💬 |
479 |
Fmt enema |
- |
- |
- |
- |
097 1件: 97💬 |
480 |
Fmt infusions |
- |
- |
- |
- |
097 1件: 97💬 |
481 |
Fmt oral |
- |
- |
- |
- |
097 1件: 97💬 |
482 |
Fosfomycin |
Fosfomycin |
4件: D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253💬 |
- |
- |
096 2件: 96, 97💬 |
483 |
Fp-110 |
- |
- |
- |
- |
097 1件: 97💬 |
484 |
Fp-cya-050 |
- |
- |
- |
- |
097 1件: 97💬 |
485 |
Fp-cya-053 |
- |
- |
- |
- |
097 1件: 97💬 |
486 |
Freeze-dried black raspberry powder |
Raspberry |
- |
- |
- |
097 1件: 97💬 |
487 |
G321605 |
- |
- |
- |
- |
085 3件: 85, 96, 97💬 |
488 |
Ganciclovir |
Ganciclovir |
2件: D00333 D00333, D04301 D04301💬 |
- |
- |
028 3件: 28, 60, 97💬 |
489 |
Gastro-resistant phosphatidylcholine granules |
Lecithin |
1件: D04682 D04682💬 |
- |
- |
097 1件: 97💬 |
490 |
Gb004 |
- |
- |
- |
- |
097 1件: 97💬 |
491 |
Ged-0301 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
492 |
Ged-0507-34-levo |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97💬 |
493 |
Ged-0507-34-levo 160 mg |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97💬 |
494 |
Ged-0507-34-levo 80 mg |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97💬 |
495 |
Ged0507 |
- |
- |
- |
- |
097 1件: 97💬 |
496 |
Gelatin |
Gelatin |
2件: D00115 D00115, D06892 D06892💬 |
- |
- |
028 4件: 28, 78, 97, 269💬 |
497 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 2件: 96, 97💬 |
498 |
Gi-270384 |
- |
- |
- |
- |
097 1件: 97💬 |
499 |
Gliolan |
- |
- |
- |
- |
097 1件: 97💬 |
500 |
Glpg0974 |
- |
- |
- |
- |
097 1件: 97💬 |
501 |
Glpg1205 |
- |
- |
- |
- |
085 3件: 85, 96, 97💬 |
502 |
Glpg3970 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
503 |
Glutamine |
L-Glutamine |
1件: D00015 D00015💬 |
- |
- |
087 7件: 87, 89, 96, 97, 113, 245, 299💬 |
504 |
Glycyrrhiza |
Glycyrrhiza glabra |
- |
- |
- |
053 2件: 53, 97💬 |
505 |
Glycyrrhiza glabra |
Glycyrrhiza glabra |
- |
- |
- |
097 1件: 97💬 |
506 |
Glycyrrhiza glabra root |
Glycyrrhiza glabra |
- |
- |
- |
097 1件: 97💬 |
507 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318💬 |
508 |
Golimumab |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271💬 |
509 |
Golimumab (glm) |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
510 |
Golimumab (optimization) |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
511 |
Golimumab 1 mg per kg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
512 |
Golimumab 100 mg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 97💬 |
513 |
Golimumab 2 mg per kg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
514 |
Golimumab 200 mg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
515 |
Golimumab 4 mg per kg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
516 |
Golimumab 400 mg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
517 |
Golimumab 50 mg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 97💬 |
518 |
Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
519 |
Golimumab dose 1 |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
520 |
Golimumab dose 2 |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
521 |
Golimumab liquid in prefilled syringe |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 84, 97💬 |
522 |
Golimumab liquid in vial |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 97, 271💬 |
523 |
Golimumab prefilled syringe |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
524 |
Golimumab treatment optimization. |
Golimumab |
1件: D04358 D04358💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97💬 |
525 |
Gralise |
- |
- |
- |
- |
097 2件: 97, 226💬 |
526 |
Granulated mesalamine |
Mesalazine |
1件: D00377 D00377💬 |
- |
- |
097 1件: 97💬 |
527 |
Grapefruit |
Grapefruit |
- |
- |
- |
006 5件: 6 , 46, 50, 83, 97💬 |
528 |
Group 1- control diet |
- |
- |
- |
- |
097 1件: 97💬 |
529 |
Group 2- ucd diet |
- |
- |
- |
- |
097 1件: 97💬 |
530 |
Gs-4875 |
- |
- |
- |
- |
097 1件: 97💬 |
531 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 4件: 46, 96, 97, 299💬 |
532 |
Gs-5745 iv |
GS-5745 |
- |
- |
- |
097 1件: 97💬 |
533 |
Gs-5745 sc |
GS-5745 |
- |
- |
- |
097 1件: 97💬 |
534 |
Gs-6034 |
- |
- |
- |
- |
046 4件: 46, 53, 96, 97💬 |
535 |
Gsk1399686 |
- |
- |
- |
- |
097 1件: 97💬 |
536 |
Gsk1605786 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
537 |
Gsk1605786a |
- |
- |
- |
- |
096 2件: 96, 97💬 |
538 |
Gsk2586184 400mg |
- |
- |
- |
- |
097 1件: 97💬 |
539 |
Gsk2831781 |
- |
- |
- |
- |
097 1件: 97💬 |
540 |
Gsk2831781 iv infusion |
- |
- |
- |
- |
097 1件: 97💬 |
541 |
Gsk2831781 sc injection |
- |
- |
- |
- |
097 1件: 97💬 |
542 |
Gsk2982772 |
- |
- |
- |
- |
046 2件: 46, 97💬 |
543 |
Gsk2982772a, where a denotes the free base |
- |
- |
- |
- |
046 2件: 46, 97💬 |
544 |
Guaiazulene |
Guaiazulen |
- |
- |
- |
097 1件: 97💬 |
545 |
Guselkum |
- |
- |
- |
- |
097 1件: 97💬 |
546 |
Guselkumab |
Guselkumab |
1件: D10438 D10438💬 |
IL23A 1件: IL23A💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 41, 96, 97💬 |
547 |
Guselkumab dose 1 |
Guselkumab |
1件: D10438 D10438💬 |
IL23A 1件: IL23A💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97💬 |
548 |
Guselkumab dose 2 |
Guselkumab |
1件: D10438 D10438💬 |
IL23A 1件: IL23A💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97💬 |
549 |
Gwp42003 |
- |
- |
- |
- |
097 1件: 97💬 |
550 |
H02ab |
- |
- |
- |
- |
097 1件: 97💬 |
551 |
He3286 |
HE3286 |
- |
- |
- |
046 2件: 46, 97💬 |
552 |
Hemay007 |
- |
- |
- |
- |
097 1件: 97💬 |
553 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 3件: 46, 96, 97💬 |
554 |
Herbal treatment (sa100) |
- |
- |
- |
- |
097 1件: 97💬 |
555 |
Hextend |
- |
- |
- |
- |
096 2件: 96, 97💬 |
556 |
Hf2 |
- |
- |
- |
- |
097 1件: 97💬 |
557 |
Hgd40 |
- |
- |
- |
- |
097 1件: 97💬 |
558 |
Hgs1025 |
- |
- |
- |
- |
097 1件: 97💬 |
559 |
High dose |
- |
- |
- |
- |
097 1件: 97💬 |
560 |
High dose budesonide |
Budesonide |
1件: D00246 D00246💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
561 |
Hmpl-004 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
562 |
Hmpl-004 1800 mg/day |
- |
- |
- |
- |
097 1件: 97💬 |
563 |
Hmpl-004 2400 mg/day |
- |
- |
- |
- |
097 1件: 97💬 |
564 |
Hmpl-004 high dose |
- |
- |
- |
- |
097 1件: 97💬 |
565 |
Hmpl-004 low dose |
- |
- |
- |
- |
097 1件: 97💬 |
566 |
Hmpl004-6599 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
567 |
Hulio |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
568 |
Hum291 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
569 |
Hum291) |
- |
- |
- |
- |
097 1件: 97💬 |
570 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97💬 |
571 |
Human anti-tnf igg1 monoclonal antibody |
- |
- |
- |
- |
046 3件: 46, 97, 271💬 |
572 |
Human anti-tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 97💬 |
573 |
Human anti-tnfalfa |
- |
- |
- |
- |
046 3件: 46, 97, 271💬 |
574 |
Humanized recombinant igg4 monoclonal antibody against cd-127 |
- |
- |
- |
- |
097 1件: 97💬 |
575 |
Humira |
- |
- |
- |
- |
046 7件: 46, 84, 96, 97, 160, 269, 271💬 |
576 |
Humira (adalimumab original) |
Adalimumab |
1件: D02597 D02597💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97💬 |
577 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: 46, 96, 97💬 |
578 |
Humira 40 mg solution for injection in pre-filled syringes |
- |
- |
- |
- |
097 1件: 97💬 |
579 |
Humira 40 mg/0.8 ml solution for injection |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
580 |
Humira 40 mg/0.8 ml solution for injection for paediatric use |
- |
- |
- |
- |
097 1件: 97💬 |
581 |
Humira 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97💬 |
582 |
Humira ® |
- |
- |
- |
- |
096 2件: 96, 97💬 |
583 |
Humira® |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271💬 |
584 |
Hyaluronate |
Hyaluronic acid |
1件: D08043 D08043💬 |
- |
- |
053 2件: 53, 97💬 |
585 |
Hydrocortisone |
Hydrocortisone |
1件: D00088 D00088💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299💬 |
586 |
Hydrocortisone acetate |
Acetate |
2件: D00088 D00088, D00165 D00165💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97💬 |
587 |
Hydrocortisone sodium succinate |
Hydrocortisone |
1件: D00088 D00088💬 |
NR3C1 1件: NR3C1💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 3件: 81, 83, 97💬 |
588 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226💬 |
589 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 4件: 46, 96, 97, 284💬 |
590 |
Hydroxocobalamin |
Hydroxocobalamin |
3件: D01027 D01027, D02707 D02707, D04929 D04929💬 |
- |
- |
097 1件: 97💬 |
591 |
Hydroxocobalamin with butyrate |
Butyric Acid |
4件: D01027 D01027, D02707 D02707, D04929 D04929, D05866 D05866💬 |
- |
- |
097 1件: 97💬 |
592 |
Ibd98-m |
- |
- |
- |
- |
097 1件: 97💬 |
593 |
Ibd98-m delayed-release capsules |
- |
- |
- |
- |
097 1件: 97💬 |
594 |
Iberogast n |
- |
- |
- |
- |
097 1件: 97💬 |
595 |
Idoform®travel |
- |
- |
- |
- |
097 1件: 97💬 |
596 |
Im90838 |
- |
- |
- |
- |
096 2件: 96, 97💬 |
597 |
Imolope |
- |
- |
- |
- |
097 1件: 97💬 |
598 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299💬 |
599 |
Imu-838 |
- |
- |
- |
- |
013 3件: 13, 96, 97💬 |
600 |
Imuran |
- |
- |
- |
- |
096 2件: 96, 97💬 |
601 |
Imurek |
- |
- |
- |
- |
097 1件: 97💬 |
602 |
Imurek 25mg filmtabletten |
- |
- |
- |
- |
097 1件: 97💬 |
603 |
Imurek 50mg filmtabletten |
- |
- |
- |
- |
097 1件: 97💬 |
604 |
Imurel |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97💬 |
605 |
Incb039110 |
- |
- |
- |
- |
051 2件: 51, 97💬 |
606 |
Inflectra |
- |
- |
- |
- |
096 2件: 96, 97💬 |
607 |
Inflectra 100 mg |
- |
- |
- |
- |
097 1件: 97💬 |
608 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 2件: 96, 97💬 |
609 |
Infliximab |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271💬 |
610 |
Infliximab (ifx) |
Infliximab |
1件: D02598 D02598💬 |
TNF 1件: TNF💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, |